CTI BIOPHARMA CORP Quarterly Common Stock, Shares Authorized from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Cti Biopharma Corp quarterly Common Stock, Shares Authorized history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 267M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 267M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 267M 0 0% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 267M 0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 267M 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 267M +100M +60.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 267M +100M +60.1% Dec 31, 2021 10-K 2023-03-06
Q3 2021 267M +100M +60.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 267M +100M +60.1% Jun 30, 2021 10-K 2023-03-06
Q1 2021 167M +35M +26.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 167M +35M +26.6% Dec 31, 2020 10-K 2022-03-31
Q3 2020 167M +35M +26.6% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 167M +35M +26.6% Jun 30, 2020 10-K 2022-03-31
Q1 2020 132M +30M +29.6% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 132M +30M +29.6% Dec 31, 2019 10-K 2021-03-17
Q3 2019 132M +30M +29.6% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 132M +30M +29.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 102M +20M +24.5% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 102M +20M +24.5% Dec 31, 2018 10-K 2020-03-13
Q3 2018 102M +20M +24.5% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 102M +20M +24.5% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 81.5M +40M +96.4% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 81.5M +40M +96.4% Dec 31, 2017 10-K 2019-03-13
Q3 2017 81.5M -334M -80.4% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 81.5M -334M -80.4% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 41.5M +10M +31.7% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 41.5M +10M +31.7% Dec 31, 2016 10-K 2018-03-07
Q3 2016 415M +100M +31.7% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 415M +100M +31.7% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 31.5M -284M -90% Mar 31, 2016 10-K 2018-03-07
Q4 2015 31.5M +10M +46.5% Dec 31, 2015 10-K 2017-03-02
Q3 2015 315M +100M +46.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 315M +100M +46.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 315M +100M +46.5% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 21.5M -194M -90% Dec 31, 2014 10-K 2017-03-02
Q3 2014 215M 0 0% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 215M 0 0% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 215M +65M +43.3% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 215M +65M +43.3% Dec 31, 2013 10-K 2015-03-12
Q3 2013 215M +65M +43.3% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 215M -168M -43.9% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 150M -233M -60.9% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 150M +73.3M +95.7% Dec 31, 2012 10-K 2014-03-04
Q3 2012 150M -133M -47.1% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 383M +100M +35.3% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 383M Mar 31, 2012 10-Q 2012-04-20
Q4 2011 76.7M -123M -61.7% Dec 31, 2011 10-K 2013-02-28
Q3 2011 283M -917M -76.4% Sep 30, 2011 10-Q 2011-10-25
Q2 2011 283M -517M -64.6% Jun 30, 2011 10-Q 2011-07-28
Q4 2010 200M Dec 31, 2010 10-K 2012-03-08
Q3 2010 1.2B Sep 30, 2010 10-Q 2010-10-28
Q2 2010 800M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.